CD4 and COVID-19: The OR for LAG3 in COVID-19 was 1.46 (95% CI: 1.11–1.92), meaning that patients with LAG3+ CD4+ TEM cells are 1.46 times more likely to develop PTB and COVID-19 infection than patients with LAG3− CD4+ TEM cells.